Mylan quietly acquired undisclosed WW rights of a product for $463mn in July'18
Shots:
- On July 30- Mylan hit a $463mn deal for the WW rights of a commercial product- without disclosing it to investors via a press release
- The deal was revealed in Mylan's Aug 8thsecond quarter earnings quarterly filing
- The company and product was undisclosed with the deal was expected to close in the second
/ article | Ref: Business Insider | Image: discovery-park
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
